Open the bottlenecks, centralise ATMP coordination, say Dutch researchers on 20/02/24
The Dutch advanced therapy medicinal products (ATMPs) field is highly fragmented and needs central coordination to unblock bottlenecks. Dutch researchers made the recommendations in a recent report offering insight gaining an efficient overview of ATMP regulations. Pharma package, Swedish MEPs split ahead of ENVI vote on 20/02/24
Swedish Members of the European Parliament welcome updated EU pharma legislation but remain divided on amendments, including on how to handle incentives for developing new antibiotics, though common ground for the Swedes exists on boosting the fight against antimicrobial resistance. No new cancer plan for Belgium, Vandenbroucke rejects calls for strategy change on 20/02/24
Belgium aims to double cancer survival rates by 2040, relying on its current cancer plan despite pharmaceutical firms calling for a new strategy. Belgian Health Minister Vandenbroucke said he prefers implementing the existing strategy to drafting a new national plan. Cancer care inequalities rage across the EU, says Swedish Institute on 20/02/24
Vast cancer care inequalities along patient pathways are highlighted in a new report from the Swedish Institute for Health Economics (IHE). Recent IHE research also shows divergence not only across the European Union, but within each country. Why a successful transplant is only half the patient journey [Promoted content] on 16/02/24
The period after a transplant poses significant challenges to patients, among them Graft-Versus-Host-Disease, and the unmet needs of post-transplant care receive limited attention. Together, we can increase awareness and ensure that transplant patients benefit from expanded treatment options and access. France to discuss assisted dying bill before summer on 15/02/24
A law on assisted dying and end-of-life measures will be discussed before summer, newly appointed French health minister Catherine Vautrin told MPs on Wednesday (14 February). EU Disability Card goes some way to improving accessibility across the bloc on 15/02/24
While broadly welcomed for harmonising accessibility measures across the bloc, the agreement on the EU's first bloc-wide Disability Card is only a first step in securing true freedom of movement within EU countries for people with disabilities, an expert told Euractiv. Limiting competition in medicines is not an option on 15/02/24
EU pharmaceutical legislation is undergoing a major reform which is an opportunity to increase people’s access to medicines, but worryingly some right-leaning political groups want to give even more power to the pharma industry, writes Monique Goyens, Director General of the European Consumer Organisation (BEUC). Athens launches first Greek language rare diseases list on 14/02/24
Greece has launched its own Rare Disease list, in Greek. Until now, no detailed classification existed for new rare diseases in the Greek language. The list is an analytical archive of every rare disease, and its sub-categories, including genetic mutations. The future of snus in Europe on 14/02/24
The EU executive is currently conducting a comprehensive evaluation of the EU legislative framework on tobacco control, the so-called Tobacco Products Directive (TPD), including via wide public consultations. The existing Directive covers traditional cigarettes and novel products and has imposed severe restrictions.
|
|
